{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:29:29Z","timestamp":1780324169263,"version":"3.54.1"},"reference-count":109,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/nrl.0b013e31816606a7","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T16:32:32Z","timestamp":1236270752000},"page":"89-99","source":"Crossref","is-referenced-by-count":58,"title":["Impulse Control Disorders and Pathological Gambling in Patients With Parkinson Disease"],"prefix":"10.1097","volume":"14","author":[{"given":"William","family":"Stamey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210211","article-title":"Diagnostic and Statistical Manual of Mental Disorder, 4th ed, Text Revision.","year":"2000"},{"key":"R2-2-20210211","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R3-2-20210211","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","article-title":"Dopamine dysregulation syndrome in Parkinson's disease.","volume":"17","author":"Evans","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R4-2-20210211","first-page":"62","article-title":"Chronic dopamimetic drug addiction and pathologic gambling in patients with Parkinson's disease-presentation of four cases.","volume":"5","author":"Serrano-Duenas","year":"2002","journal-title":"Ger J Psychiatry"},{"key":"R5-2-20210211","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(03)00529-5","article-title":"Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?","volume":"2","author":"Lawrence","year":"2003","journal-title":"Lancet Neurol"},{"key":"R6-2-20210211","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1212\/01.WNL.0000094200.44303.F3","article-title":"Levodopa addiction in non-parkinsonian patients.","volume":"61","author":"Steiner","year":"2003","journal-title":"Neurology"},{"key":"R7-2-20210211","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","article-title":"Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease.","volume":"65","author":"Evans","year":"2005","journal-title":"Neurology"},{"key":"R8-2-20210211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mds.20288","article-title":"Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease.","volume":"20","author":"Pezzella","year":"2005","journal-title":"Mov Disord"},{"key":"R9-2-20210211","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1176\/ps.49.11.1434","article-title":"Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior.","volume":"49","author":"Black","year":"1998","journal-title":"Psychiatr Serv"},{"key":"R10-2-20210211","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.biopsych.2005.04.037","article-title":"Cue-induced brain activity in pathological gamblers.","volume":"58","author":"Crockford","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R11-2-20210211","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1525-1497.2002.10812.x","article-title":"Gambling: an addictive behavior with health and primary care implications.","volume":"17","author":"Potenza","year":"2002","journal-title":"J Gen Intern Med"},{"key":"R12-2-20210211","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4088\/JCP.v66n0504","article-title":"Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"66","author":"Petry","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R13-2-20210211","first-page":"85","article-title":"Pathological Gambling. Etiology, Comorbidity, and Treatment.","author":"Petry","year":"2005"},{"key":"R15-2-20210211","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?","volume":"15","author":"Molina","year":"2000","journal-title":"Mov Disord"},{"key":"R16-2-20210211","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00002826-200105000-00009","article-title":"Pathologic gambling in patients with Parkinson's disease.","volume":"24","author":"Gschwandtner","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"R17-2-20210211","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jnnp.70.3.394","article-title":"Obsessive-compulsive symptoms in Parkinson's disease.","volume":"70","author":"Alegret","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R18-2-20210211","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(02)11339-0","article-title":"Compulsions, Parkinson's disease, and stimulation.","volume":"360","author":"Mallet","year":"2002","journal-title":"Lancet"},{"key":"R19-2-20210211","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"},{"key":"R20-2-20210211","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/mds.21296","article-title":"Punding prevalence in Parkinson's disease.","volume":"22","author":"Miyasaki","year":"2007","journal-title":"Mov Disord"},{"key":"R21-2-20210211","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinson's disease.","volume":"19","author":"Kurlan","year":"2004","journal-title":"Mov Disord"},{"key":"R22-2-20210211","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease.","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"R23-2-20210211","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"R24-2-20210211","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease.","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"R25-2-20210211","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.20046","article-title":"Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease.","volume":"19","author":"Voon","year":"2004","journal-title":"Mov Disord"},{"key":"R26-2-20210211","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/mds.20787","article-title":"Punding and computer addiction in Parkinson's disease.","volume":"21","author":"Fasano","year":"2006","journal-title":"Mov Disord"},{"key":"R27-2-20210211","article-title":"Clinical Psychiatry: A Textbook for Students and Physicians.","author":"Kraepelin","year":"1907"},{"key":"R28-2-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.publhealth.23.100901.140532","article-title":"Gambling and related mental disorders: a public health analysis.","volume":"23","author":"Shaffer","year":"2002","journal-title":"Annu Rev Public Health"},{"key":"R29-2-20210211","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2105\/AJPH.89.9.1369","article-title":"Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis.","volume":"89","author":"Shaffer","year":"1999","journal-title":"Am J Public Health"},{"key":"R30-2-20210211","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF03404298","article-title":"Updating and refining prevalence estimates of disordered gambling behaviour in the United States and Canada.","volume":"92","author":"Shaffer","year":"2001","journal-title":"Can J Public Health"},{"key":"R31-2-20210211","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2105\/AJPH.88.7.1093","article-title":"Taking chances: problem gamblers and mental health disorder-results from the St. Louis Epidemiologic Catchment Area Study.","volume":"88","author":"Cunningham-Williams","year":"1998","journal-title":"Am J Public Health"},{"key":"R32-2-20210211","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","article-title":"Prevalence of pathological gambling in patients with Parkinson's disease.","volume":"21","author":"Avanzi","year":"2006","journal-title":"Mov Disord"},{"key":"R33-2-20210211","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1017\/S1092852900015121","article-title":"The genetics of gambling and behavioral addictions.","volume":"11","author":"Lobo","year":"2006","journal-title":"CNS Spectr"},{"key":"R34-2-20210211","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10072-004-0238-z","article-title":"Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.","volume":"25","author":"Avanzi","year":"2004","journal-title":"Neurol Sci"},{"key":"R35-2-20210211","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archneur.63.2.299-b","article-title":"Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event Database.","volume":"63","author":"Szarfman","year":"2006","journal-title":"Arch Neurol"},{"key":"R36-2-20210211","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/mds.21110","article-title":"Problematic gambling on dopamine agonists: not such a rarity.","volume":"21","author":"Grosset","year":"2006","journal-title":"Mov Disord"},{"key":"R37-2-20210211","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","article-title":"Prospective prevalence of pathologic gambling and medication association in Parkinson disease.","volume":"66","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"R38-2-20210211","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jnnp.2005.065417","article-title":"Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease.","volume":"77","author":"Evans","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R39-2-20210211","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.33.7.815","article-title":"Parkinson's disease in 65 pairs of twins and in a set of quadruplets.","volume":"33","author":"Ward","year":"1983","journal-title":"Neurology"},{"key":"R40-2-20210211","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.20307","article-title":"Risk and protective factors for Parkinson's disease: a study in Swedish twins.","volume":"57","author":"Wirdefeldt","year":"2005","journal-title":"Ann Neurol"},{"key":"R41-2-20210211","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.","volume":"52","author":"Hernan","year":"2002","journal-title":"Ann Neurol"},{"key":"R42-2-20210211","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","article-title":"Factors associated with dopaminergic medication-related pathological gambling in Parkinson disease.","volume":"64","author":"Voon","year":"2007","journal-title":"Arch Neurol"},{"key":"R44-2-20210211","first-page":"26","article-title":"Obsessive-compulsive symptoms and motor asymmetries in Parkinson's disease.","volume":"6","author":"Tomer","year":"1993","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"R45-2-20210211","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-1781(97)02658-9","article-title":"Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease.","volume":"70","author":"M\u00fcller","year":"1997","journal-title":"Psychiatry Res"},{"key":"R46-2-20210211","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/jnp.15.3.371","article-title":"Obsessive-compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson's disease.","volume":"15","author":"Maia","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R47-2-20210211","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1345\/aph.1A412","article-title":"Possible zoophilia associated with dopaminergic therapy in Parkinson's disease.","volume":"36","author":"Jimenez-Jimenez","year":"2002","journal-title":"Ann Pharmacother"},{"key":"R48-2-20210211","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"R49-2-20210211","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1017\/S1092852900015133","article-title":"Impulsive-compulsive sexual behavior.","volume":"11","author":"Mick","year":"2006","journal-title":"CNS Spect"},{"key":"R50-2-20210211","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.parkreldis.2006.01.010","article-title":"Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases.","volume":"12","author":"Shapiro","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"R51-2-20210211","article-title":"Synopsis of Psychiatry. 7th ed.","author":"Kaplan","year":"1994"},{"key":"R52-2-20210211","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","article-title":"Clinical features associated with impulse control disorders in Parkinson disease.","volume":"67","author":"Pontone","year":"2006","journal-title":"Neurology"},{"key":"R53-2-20210211","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00002826-200207000-00008","article-title":"Reversible transvestic fetishism in a man with parkinson's disease treated with selegiline.","volume":"25","author":"Riley","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"R54-2-20210211","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/WNL.45.4.753","article-title":"Stereotactic ventral pallidotomy for Parkinson's disease.","volume":"45","author":"Dogali","year":"1995","journal-title":"Neurology"},{"key":"R55-2-20210211","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1212\/WNL.50.2.434","article-title":"Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients.","volume":"50","author":"Shannon","year":"1998","journal-title":"Neurology"},{"key":"R56-2-20210211","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/jnp.16.1.37","article-title":"Hypersexuality after right pallidotomy for Parkinson's disease.","volume":"16","author":"Mendez","year":"2004","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R57-2-20210211","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.2006.102061","article-title":"Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease.","volume":"78","author":"Smeding","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R58-2-20210211","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use.","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Mov Disord"},{"key":"R59-2-20210211","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000091825","article-title":"Food habits and intake of nutrients in elderly patients with Parkinson's disease.","volume":"52","author":"Loref\u00e4lt","year":"2006","journal-title":"Gerontology"},{"key":"R60-2-20210211","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/mds.20837","article-title":"Predictors of weight loss in Parkinson's disease.","volume":"21","author":"Uc","year":"2006","journal-title":"Mov Disord"},{"key":"R61-2-20210211","first-page":"S599","article-title":"Craving sweets in Parkinson's disease.","volume":"21","author":"Shahed","year":"2006","journal-title":"Mov Disord"},{"key":"R62-2-20210211","first-page":"S187","article-title":"Chocolate consumption is increased in Parkinson's disease.","volume":"22","author":"Wolz","year":"2007","journal-title":"Mov Disord"},{"key":"R64-2-20210211","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L","article-title":"Impulsivity, aggression, and serotonin: a molecular psychobiological perspective.","volume":"18","author":"Lesch","year":"2000","journal-title":"Behav Sci Law"},{"key":"R65-2-20210211","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nature05051","article-title":"Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans.","volume":"442","author":"Pessiglione","year":"2006","journal-title":"Nature"},{"key":"R66-2-20210211","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrn1919","article-title":"The role of the basal ganglia in habit formation.","volume":"7","author":"Yin","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"R67-2-20210211","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/mds.21457","article-title":"Controlled study of decision-making and cognitive impairment in Parkinson's disease.","volume":"22","author":"Pagonabarraga","year":"2007","journal-title":"Mov Disord"},{"key":"R68-2-20210211","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1997.tb52356.x","article-title":"Insights into the neurobiology and impulsive behavior from serotonin receptor knockout mice.","volume":"836","author":"Brunner","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"R69-2-20210211","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice.","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"R70-2-20210211","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4615-4709-9_7","article-title":"Plasma L-tryptophan depletion and aggression.","volume":"467","author":"Dougherty","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"R71-2-20210211","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1126\/science.1060818","article-title":"Impulsive choice induced in rats by lesions of the nucleus accumbens core.","volume":"292","author":"Cardinal","year":"2001","journal-title":"Science"},{"key":"R72-2-20210211","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/1073858406293154","article-title":"Hedonic hot spots in the brain.","volume":"12","author":"Pecina","year":"2006","journal-title":"Neuroscientist"},{"key":"R73-2-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1212\/01.wnl.0000250354.81556.90","article-title":"GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric co-morbidities.","volume":"68","author":"Shahed","year":"2007","journal-title":"Neurology"},{"key":"R74-2-20210211","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11920-000-0027-1","article-title":"The personality associated with Parkinson's disease.","volume":"2","author":"Menza","year":"2000","journal-title":"Curr Psychiatry Rep"},{"key":"R75-2-20210211","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1077349","article-title":"Discrete coding of reward probability and uncertainty by dopamine neurons.","volume":"299","author":"Fiorillo","year":"2003","journal-title":"Science"},{"key":"R76-2-20210211","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nn1840","article-title":"Post-decision wagering objectively measures awareness.","volume":"10","author":"Persaud","year":"2007","journal-title":"Nat Neurosci"},{"key":"R77-2-20210211","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.1134239","article-title":"The neural basis of loss aversion in decision-making under risk.","volume":"315","author":"Tom","year":"2007","journal-title":"Science"},{"key":"R78-2-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","article-title":"Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.","volume":"30","author":"Cools","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"R79-2-20210211","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nn1378","article-title":"Pathological gambling is linked to reduced activation of the mesolimbic reward system.","volume":"8","author":"Reuter","year":"2005","journal-title":"Nat Neurosci"},{"key":"R80-2-20210211","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons.","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"R81-2-20210211","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.brainresbull.2006.06.010","article-title":"Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.","volume":"70","author":"Pritchard","year":"2006","journal-title":"Brain Res Bull"},{"key":"R82-2-20210211","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa.","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R83-2-20210211","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0896-6273(02)00967-4","article-title":"Getting formal with dopamine and reward.","volume":"36","author":"Schultz","year":"2002","journal-title":"Neuron"},{"key":"R84-2-20210211","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/nm1106-1244","article-title":"Feeding signals and drugs meet in the midbrain.","volume":"12","author":"Simerly","year":"2006","journal-title":"Nat Med"},{"key":"R85-2-20210211","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1097\/00001756-200011270-00019","article-title":"Reduced reward processing in the brains of Parkinsonian patients.","volume":"11","author":"Kunig","year":"2000","journal-title":"NeuroReport"},{"key":"R86-2-20210211","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease.","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"R88-2-20210211","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1073\/pnas.87.17.6912","article-title":"Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum.","volume":"87","author":"Graybiel","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"R89-2-20210211","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nlm.2004.10.006","article-title":"Stimulant-induced adaptations in neostriatal matrix and striosome systems: transiting from instrumental responding to habitual behavior in drug addiction.","volume":"83","author":"Canales","year":"2005","journal-title":"Neurobiol Learn Mem"},{"key":"R90-2-20210211","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1073\/pnas.95.11.6486","article-title":"Preferential localization of self-stimulation sites in striosomes\/patches in the rat striatum.","volume":"95","author":"White","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"R91-2-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)90856-7","article-title":"Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.","volume":"659","author":"Leh\u00e9ricy","year":"1994","journal-title":"Brain Res"},{"key":"R92-2-20210211","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","article-title":"Early loss of neostriatal striosomes neurons in Huntington's disease.","volume":"54","author":"Hedreen","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"R93-2-20210211","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/brain\/awl243","article-title":"Striosomes and mood dysfunction in Huntington's disease.","volume":"130","author":"Tippett","year":"2007","journal-title":"Brain"},{"key":"R94-2-20210211","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathological gambling.","volume":"47","author":"Hollander","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R95-2-20210211","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.","volume":"49","author":"Kim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R96-2-20210211","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004850-200109000-00006","article-title":"An open naltrexone treatment study in pathological gambling disorder.","volume":"16","author":"Kim","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"R97-2-20210211","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","article-title":"A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.","volume":"63","author":"Kim","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R98-2-20210211","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","article-title":"A pilot placebo-controlled study of fluvoxamine for pathological gambling.","volume":"14","author":"Blanco","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"R99-2-20210211","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.yic.0000073881.93678.21","article-title":"Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial.","volume":"18","author":"Grant","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"R100-2-20210211","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4088\/JCP.v63n0109","article-title":"An open label study of citalopram in the treatment of pathological gambling.","volume":"63","author":"Zimmerman","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R101-2-20210211","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4088\/JCP.v63n1114","article-title":"Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.","volume":"63","author":"Pallanti","year":"","journal-title":"J Clin Psychiatry"},{"key":"R102-2-20210211","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.jcp.0000186867.90289.ed","article-title":"Sustained-release bupropion versus naltrexone in the treatment of pathological gambling.","volume":"25","author":"Dannon","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R103-2-20210211","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R104-2-20210211","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/00005053-200111000-00007","article-title":"Cognitive treatment of pathological gambling.","volume":"189","author":"Ladouceur","year":"2001","journal-title":"J Nerv Ment Dis"},{"key":"R105-2-20210211","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3171\/jns.2004.100.6.1084","article-title":"Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report.","volume":"100","author":"Fontaine","year":"2004","journal-title":"J Neurosurg"},{"key":"R106-2-20210211","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.parkreldis.2006.07.011","article-title":"Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.","volume":"13","author":"Bandini","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"R107-2-20210211","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/mds.20501","article-title":"Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation.","volume":"20","author":"Witjas","year":"2005","journal-title":"Mov Disord"},{"key":"R108-2-20210211","first-page":"2983","article-title":"Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 8th ed.","author":"Rauch","year":"2005"},{"key":"R109-2-20210211","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.mjt.0000151861.59698.26","article-title":"Effects of donepezil on compulsive hypersexual behavior in Parkinson's disease.","volume":"12","author":"Ivanco","year":"2005","journal-title":"Am J Ther"},{"key":"R110-2-20210211","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1517\/14656566.7.17.2341","article-title":"New pharmacological approaches for the treatment of alcoholism.","volume":"7","author":"Soyka","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"R114-2-20210211","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/mds.21696","article-title":"Assessment of psychiatric complications in Parkinson's disease: the SCOPA-PC.","volume":"22","author":"Visser","year":"2007","journal-title":"Mov Disord"},{"key":"R116-2-20210211","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0680","article-title":"Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease.","volume":"3","author":"Potenza","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"R117-2-20210211","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/wnf.0b013e31804c780e","article-title":"Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.","volume":"30","author":"Driver-Dunckley","year":"2007","journal-title":"Clin Neuropharmacol"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00127893-200803000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:23:38Z","timestamp":1618035818000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-200803000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e31816606a7","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}